GE HealthCare Technologies Inc.
GEHC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.41 | -0.80 | -1.00 | 1.09 |
| FCF Yield | 4.35% | 4.87% | 6.80% | 4.98% |
| EV / EBITDA | 11.49 | 12.11 | 10.64 | 7.67 |
| Quality | ||||
| ROIC | 8.29% | 6.79% | 9.56% | 11.25% |
| Gross Margin | 41.71% | 40.52% | 39.14% | 40.80% |
| Cash Conversion Ratio | 0.95 | 1.30 | 1.08 | 0.71 |
| Growth | ||||
| Revenue 3-Year CAGR | 2.36% | 3.60% | 2.24% | 1.87% |
| Free Cash Flow Growth | -9.57% | -4.94% | 32.67% | -4.83% |
| Safety | ||||
| Net Debt / EBITDA | 1.77 | 2.09 | 2.27 | -0.03 |
| Interest Coverage | 5.20 | 4.49 | 29.33 | 69.88 |
| Efficiency | ||||
| Inventory Turnover | 5.91 | 5.93 | 5.18 | 5.35 |
| Cash Conversion Cycle | 46.72 | 49.58 | 48.89 | 51.24 |